Adjuvant treatment in breast cancer
暂无分享,去创建一个
T. Powles | W. Allum | I. Smith | H. Goodare | A. Rostom | P. Plowman | B. Zumoff | A. Gershuny | H. Kaplan
[1] H. Kaplan,et al. A neglected issue: the sexual side effects of current treatments for breast cancer. , 1992, Journal of sex & marital therapy.
[2] W. Gregory,et al. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. , 1990, BMJ.
[3] R. Love. Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] K. Goa,et al. Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. , 1989, Drugs.
[5] J. Haybittle,et al. LONG-TERM SURVIVAL OF WOMEN WITH BREAST CANCER , 1984, The Lancet.
[6] G. Secreto,et al. Paradoxical effects associated with supranormal urinary testosterone excretion in premenopausal women with breast cancer: increased risk of postmastectomy recurrence and higher remission rate after ovariectomy. , 1983, Cancer research.
[7] D. Rose,et al. Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients. , 1980, Cancer research.
[8] J. Haybittle,et al. Curability of breast cancer. , 1991, British medical bulletin.
[9] J. Haybittle,et al. THE CURABILITY OF BREAST CANCER , 1975, The Lancet.
[10] W. Sircus. Letters to the EditorANTRAL-GASTRIN-CELL HYPERPLASIA IN PEPTIC-ULCER DISEASE , 1974 .